Lecture

Right Arrow

SEARCH COURSES / LECTURES

Left Arrow

Healthcare Finance (Spring 2019) (M-I-T)

(152 Lectures Available)

S# Lecture Course Institute Instructor Discipline
76
  • NPV Rule & Cash Flows (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
77
  • Options  (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
78
  • Origins of Option Pricing Theory (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
79
  • Orphan Drug Financials (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
80
  • Our Three Pricing Formulas (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
81
  • Overview of Stock and Bond Markets (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
82
  • Overview of the Results (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
83
  • Pablo Legorretta: Royalty Pharma (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
84
  • Perpetuities (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
85
  • Phil Reilly: Third Rock Ventures (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
86
  • Portfolio Theory (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
87
  • Portfolio Theory in a Biomedical Context (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
88
  • Practical Considerations (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
89
  • Predictive Analytics for Drug Approvals and Clinical-Phase Transitions  (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
90
  • Present Value  (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
91
  • Pricing (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
92
  • Pricing, Value, and Ethics (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
93
  • Raising Capital (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
94
  • Real Options (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
95
  • Results & Implications (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
96
  • Returns (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
97
  • Risk and Return in the Biopharma Industries  (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
98
  • Risk and Reward (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
99
  • Robert Langer: MIT Langer Lab (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences
100
  • Roger Stein: Research-Backed Obligations (M-I-T)
Healthcare Finance (Spring 2019) (M-I-T) MIT Prof. Andrew Lo Applied Sciences